nti_article_03

Sunstone BioSciences, Inc.

Sunstone BioSciences, Inc., a cancer treatment company, is currently developing nanoparticles as photosensitizer delivery and activation systems that will allow for preferential tumor uptake. The company’s products have been licensed to a major biopharmaceutical company. Sunstone is a subsidiary of Intelligent Materials Solutions.

www.intmatsol.com

Why Is Small So Big?

Nanotechnology deals with products and processes that are measured in almost unbelievably small increments called “nanometers”—one billionth of a meter.

At the nanoscale, materials differ from larger objects in their physical, chemical and biological properties; therefore, they lend themselves to new and improved materials, systems and devices. Nanotechnology is behind the development of such diverse advancements as:

  1. Drug Delivery
  2. Biofiltration and Separation sciences
  3. Improved coatings for medical devices

Thanks to rapid advances in this exciting new field, we now have the tools and talents to manipulate materials on the molecular scale—a technology literally changing the world as we know it.


The NTI is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.